» Articles » PMID: 9143550

High Glucose Reduces Generation of Plasmin Activity by Mesangial Cells

Overview
Journal Microvasc Res
Date 1997 Mar 1
PMID 9143550
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Mesangium enlargement is a central feature of diabetic nephropathy and almost certainly plays a pathogenic role in this condition. Previous studies have shown that mesangium degradation is reduced in a high glucose mileau. Plasmin has been shown to play an important role in extracellular matrix degradation, both directly and through its ability to activate the matrix metalloproteinases. We therefore investigated how high glucose concentration may affect the various components of the plasminogen cascade on mesangial cells and whether it impairs the ability of the mesangial cell to generate plasmin activity. Result showed decreased binding of plasminogen and the urokinase type plasminogen activator to the mesangial cell surface while the tissue type plasminogen activator and the plasminogen activator-1 associated with mesangial cells were increased. The net effect of these changes was a reduced capacity of mesangial cell layers to generate plasmin activity in a high glucose environment. We postulate that this may be of importance in the reduced mesangium degradation which occurs in diabetes.

Citing Articles

GYY4137 Regulates Extracellular Matrix Turnover in the Diabetic Kidney by Modulating Retinoid X Receptor Signaling.

Juin S, Pushpakumar S, Sen U Biomolecules. 2021; 11(10).

PMID: 34680110 PMC: 8533431. DOI: 10.3390/biom11101477.


Effect of crocin on antioxidant gene expression, fibrinolytic parameters, redox status and blood biochemistry in nicotinamide-streptozotocin-induced diabetic rats.

Margaritis I, Angelopoulou K, Lavrentiadou S, Mavrovouniotis I, Tsantarliotou M, Taitzoglou I J Biol Res (Thessalon). 2020; 27:4.

PMID: 32161725 PMC: 7053078. DOI: 10.1186/s40709-020-00114-5.


Deficiency of Urokinase Plasminogen Activator May Impair β Cells Regeneration and Insulin Secretion in Type 2 Diabetes Mellitus.

Wu C, Ou S, Chang L, Lin Y, Pei D, Chen J Molecules. 2019; 24(23).

PMID: 31756973 PMC: 6930534. DOI: 10.3390/molecules24234208.


Plasminogen activator inhibitor-1 antisense oligodeoxynucleotides abrogate mesangial fibronectin accumulation.

Park J, Seo J, Ha H Korean J Physiol Pharmacol. 2011; 14(6):385-90.

PMID: 21311679 PMC: 3034118. DOI: 10.4196/kjpp.2010.14.6.385.


Abnormalities in signaling pathways in diabetic nephropathy.

Brosius F, Khoury C, Buller C, Chen S Expert Rev Endocrinol Metab. 2010; 5(1):51-64.

PMID: 20224802 PMC: 2834210. DOI: 10.1586/eem.09.70.